Cytokinetics (CYTK) Net Margin (2016 - 2025)
Historic Net Margin for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to 1655.61%.
- Cytokinetics' Net Margin rose 97047700.0% to 1655.61% in Q4 2024 from the same period last year, while for Dec 2024 it was 7765.51%, marking a year-over-year increase of 147311300.0%. This contributed to the annual value of 1522.37% for FY2024, which is 84879900.0% up from last year.
- Per Cytokinetics' latest filing, its Net Margin stood at 1655.61% for Q4 2024, which was up 97047700.0% from 32338.88% recorded in Q3 2024.
- Cytokinetics' Net Margin's 5-year high stood at 1655.61% during Q4 2024, with a 5-year trough of 57391.16% in Q2 2024.
- For the 5-year period, Cytokinetics' Net Margin averaged around 9414.31%, with its median value being 2459.95% (2021).
- Within the past 5 years, the most significant YoY rise in Cytokinetics' Net Margin was 97047700bps (2024), while the steepest drop was -425014300bps (2024).
- Cytokinetics' Net Margin (Quarter) stood at 320.68% in 2020, then crashed by -120bps to 64.69% in 2021, then plummeted by -10492bps to 6851.66% in 2022, then dropped by -17bps to 8049.16% in 2023, then skyrocketed by 121bps to 1655.61% in 2024.
- Its last three reported values are 1655.61% in Q4 2024, 32338.88% for Q3 2024, and 57391.16% during Q2 2024.